title: Genomics in multiple myeloma research.
abstract: Multiple myeloma (MM) is the second most common hematological cancer. It is a very heterogeneous disease characterized by large genomic complexity, recurrent amplifications and/or deletions in the genome leading to different clinical manifestations and survival of patients. Thus, genomics plays an important role in identifying agents responsible for pathogenesis, prognosis and disease stratification of MM.
authors.affiliation: Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
authors.forename: S
authors.initials: S
authors.lastname: Sevcíková
authors.forename: P
authors.initials: P
authors.lastname: Nemec
authors.forename: L
authors.initials: L
authors.lastname: Pour
authors.forename: R
authors.initials: R
authors.lastname: Hájek
mesh_terms: D020869:Gene Expression Profiling; D055106:Genome-Wide Association Study; D023281:Genomics; D006801:Humans; D009101:Multiple Myeloma / Q000235:genetics*; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide